Clinical and in Vitro Evaluation of New Anti-redness Cosmetic Products in Subjects with Winter Xerosis and Sensitive Skin

Overview

Journal Int J Cosmet Sci

Specialty Dermatology

Date 2019 Jul 17

PMID 31309600

Citations 6

Authors

S J Nisbet

D Targett

A V Rawlings

K Qian

X Wang

C B Lin

M A Thompson

P A Bulsara

D J Moore

Affiliations

Soon will be listed here.

Abstract

Objective: To demonstrate the in vitro activities of panthenol, palmitoylethanolamide (PEA), and niacinamide (NAM) and determine the biophysical properties, clinical safety, tolerability together with efficacy of two developmental anti-redness (AR) formulations containing these ingredients, in alleviating facial redness associated with winter xerosis in healthy volunteers with sensitive skin.

Methods: The anti-inflammatory and skin protective properties of panthenol, PEA and NAM were evaluated in vitro. The physical properties of the AR formulations were analysed using measurement of water vapour transport rate (WVTR) and infrared spectroscopy. Clinical studies were performed between the months of December and April (2014-2015) with efficacy assessed during the winter. Facial redness, irritation, sensitization potential, photo-irritation, and photo-sensitization were evaluated. Self-assessed adverse reactions were reported in diaries of use.

Results: Panthenol and PEA reduced prostaglandin E , interleukin-6, and thymic stromal lymphopoietin levels in vitro, while NAM induced nicotinamide adenine dinucleotide (NAD) levels and the keratinocyte differentiation markers: filaggrin (2-fold increase, P < 0.001), loricrin (2-fold increase, P < 0.05), involucrin (2 fold increase, P < 0.001) & peroxisomal proliferator activated receptor-alpha (1.5 fold increase, P < 0.05). The two AR products exhibited low WVTR vs. no treatment (P < 0.001) and displayed an ordered lipid structure. The day cream formulation protected against ultraviolet B radiation in vitro. A total of 382 participants were included in clinical studies which showed the AR formulations significantly improved facial redness associated with winter xerosis (Day 29 mean change from baseline: AR day cream 0.77 (P < 0.001); AR serum 0.67 (P < 0.001)). No irritation, sensitization, photo-irritation, photo-sensitization or product-related adverse reactions were observed or reported in the clinical studies.

Conclusion: The new products significantly improved skin redness associated with winter xerosis in participants with self-perceived sensitive skin. Both products were well tolerated with a suitable safety profile for topical use in subjects with sensitive skin.

Citing Articles

Management of triggering factor effects in sensitive skin syndrome with a dermo-cosmetic product.

Polena H, Fontbonne A, Abric E, Lecerf G, Chavagnac-Bonneville M, Moga A J Cosmet Dermatol. 2024; 23(12):4325-4333.

PMID: 39291708 PMC: 11626381. DOI: 10.1111/jocd.16529.

Effect of Topical Platelet Extract Daily Serum as a Cosmetic Product to Reduce Facial Redness.

Kaufman-Janette J, Cazzaniga A, Jacobson A, Eaton Jankov L, Copeland K, Behfar A J Clin Aesthet Dermatol. 2023; 16(10):48-51.

PMID: 37915335 PMC: 10617900.

The role of macrophages in rosacea: implications for targeted therapies.

Liu Y, Zhou Y, Chu C, Jiang X Front Immunol. 2023; 14:1211953.

PMID: 37691916 PMC: 10484341. DOI: 10.3389/fimmu.2023.1211953.

Systematic Study of Paeonol/Madecassoside Co-Delivery Nanoemulsion Transdermal Delivery System for Enhancing Barrier Repair and Anti-Inflammatory Efficacy.

Lu W, Luo D, Chen D, Zhang S, Chen X, Zhou H Molecules. 2023; 28(13).

PMID: 37446936 PMC: 10343821. DOI: 10.3390/molecules28135275.

Edible Bird's Nest, an Asian Health Food Supplement, Possesses Moisturizing Effect by Regulating Expression of Filaggrin in Skin Keratinocyte.

Lai Q, Guo M, Wu K, Liao Z, Guan D, Dong T Front Pharmacol. 2021; 12:685982.

PMID: 34354585 PMC: 8329658. DOI: 10.3389/fphar.2021.685982.

References

Eberlein B, Eicke C, Reinhardt H, Ring J . Adjuvant treatment of atopic eczema: assessment of an emollient containing N-palmitoylethanolamine (ATOPA study). J Eur Acad Dermatol Venereol. 2008; 22(1):73-82. DOI: 10.1111/j.1468-3083.2007.02351.x. View

Hernandez-Pigeon H, Garidou L, Galliano M, Delga H, Aries M, Duplan H . Effects of dextran sulfate, 4-t-butylcyclohexanol, pongamia oil and hesperidin methyl chalcone on inflammatory and vascular responses implicated in rosacea. Clin Cosmet Investig Dermatol. 2018; 11:421-429. PMC: 6135068. DOI: 10.2147/CCID.S168621. View

Proksch E, de Bony R, Trapp S, Boudon S . Topical use of dexpanthenol: a 70th anniversary article. J Dermatolog Treat. 2017; 28(8):766-773. DOI: 10.1080/09546634.2017.1325310. View

Tanno O, Ota Y, Kitamura N, Katsube T, Inoue S . Nicotinamide increases biosynthesis of ceramides as well as other stratum corneum lipids to improve the epidermal permeability barrier. Br J Dermatol. 2000; 143(3):524-31. DOI: 10.1111/j.1365-2133.2000.03705.x. View

Yuan C, Wang X, Guichard A, Tan Y, Qian C, Yang L . N-palmitoylethanolamine and N-acetylethanolamine are effective in asteatotic eczema: results of a randomized, double-blind, controlled study in 60 patients. Clin Interv Aging. 2014; 9:1163-9. PMC: 4111646. DOI: 10.2147/CIA.S65448. View

Grivet-Seyve M, Santoro F, Lachmann N . Evaluation of a novel very high sun-protection-factor moisturizer in adults with rosacea-prone sensitive skin. Clin Cosmet Investig Dermatol. 2017; 10:211-219. PMC: 5476437. DOI: 10.2147/CCID.S134857. View

Kligman A, Wooding W . A method for the measurement and evaluation of irritants on human skin. J Invest Dermatol. 1967; 49(1):78-94. DOI: 10.1038/jid.1967.106. View

Ehnis-Perez A, Torres-Alvarez B, Cortes-Garcia D, Hernandez-Blanco D, Fuentes-Ahumada C, Castanedo-Cazares J . Relationship between transient receptor potential vanilloid-1 expression and the intensity of sensitive skin symptoms. J Cosmet Dermatol. 2015; 15(3):231-7. DOI: 10.1111/jocd.12204. View

Wilson S, The L, Batia L, Beattie K, Katibah G, McClain S . The epithelial cell-derived atopic dermatitis cytokine TSLP activates neurons to induce itch. Cell. 2013; 155(2):285-95. PMC: 4041105. DOI: 10.1016/j.cell.2013.08.057. View

10.

Dubrac S, Schmuth M . PPAR-alpha in cutaneous inflammation. Dermatoendocrinol. 2011; 3(1):23-6. PMC: 3051849. DOI: 10.4161/derm.3.1.14615. View

11.

Blander G, Bhimavarapu A, Mammone T, Maes D, Elliston K, Reich C . SIRT1 promotes differentiation of normal human keratinocytes. J Invest Dermatol. 2008; 129(1):41-9. PMC: 3526938. DOI: 10.1038/jid.2008.179. View

12.

Huang L, Zhong Y, Liu D, Wang X, Gong C, Wen S . Adverse cutaneous reactions to skin care products on the face vary with age, but not with sex. Contact Dermatitis. 2018; 79(6):365-369. PMC: 6234074. DOI: 10.1111/cod.13102. View

13.

Narbutt J, Philipsen P, Harrison G, Morgan K, Lawrence K, Baczynska K . Sunscreen applied at ≥ 2 mg cm during a sunny holiday prevents erythema, a biomarker of ultraviolet radiation-induced DNA damage and suppression of acquired immunity. Br J Dermatol. 2018; 180(3):604-614. DOI: 10.1111/bjd.17277. View

14.

Weber T, Ceilley R, Buerger A, Kolbe L, Trookman N, Rizer R . Skin tolerance, efficacy, and quality of life of patients with red facial skin using a skin care regimen containing Licochalcone A. J Cosmet Dermatol. 2006; 5(3):227-32. DOI: 10.1111/j.1473-2165.2006.00261.x. View

15.

Jovanovic Z, Angabini N, Ehlen S, Bukvic Mokos Z, Subotic M, Neufang G . Efficacy and Tolerability of a Cosmetic Skin Care Product With Trans-4-t-butylcyclohexanol and Licochalcone A in Subjects With Sensitive Skin Prone to Redness and Rosacea. J Drugs Dermatol. 2017; 16(6):605-610. View

16.

Sulzberger M, Worthmann A, Holtzmann U, Buck B, Jung K, Schoelermann A . Effective treatment for sensitive skin: 4-t-butylcyclohexanol and licochalcone A. J Eur Acad Dermatol Venereol. 2016; 30 Suppl 1:9-17. DOI: 10.1111/jdv.13529. View

17.

Draelos Z, Levy S, Lutrario C, Gunt H . Evaluation of the Performance of a Nature-Based Sensitive Skin Regimen in Subjects With Clinically Diagnosed Sensitive Skin. J Drugs Dermatol. 2018; 17(8):908-913. View

18.

Dupont E, Leveille C, Gomez J, Loigeret M, Loing E, Bilodeau D . Clinical efficacy of a serum integrating multiple cosmetic ingredients in the management of erythema of the face in aging skin. J Cosmet Dermatol. 2012; 11(3):207-12. DOI: 10.1111/j.1473-2165.2012.00623.x. View

19.

Jung Y, Lee J, Bae J, Lee D, Kim G . Assessment of the efficacy and safety of a new complex skin cream in Asian women: A controlled clinical trial. J Cosmet Dermatol. 2017; 16(2):253-257. DOI: 10.1111/jocd.12338. View

20.

Rawlings A . Molecular basis for stratum corneum maturation and moisturization. Br J Dermatol. 2014; 171 Suppl 3:19-28. DOI: 10.1111/bjd.13303. View